Luca Reggiani Bonetti et. al, Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer
Sabrina Arena et. al, Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer
Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.
Roberta Minari et. al, Concurrent acquired BRAF V600E mutation and MET amplification as resistance mechanism of first-line osimertinib treatment in NSCLC EGFR-mutated patient.
Lorena Gurrieri et. al, MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme”
Fabrizio Tabbò et. al, Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma